Lexaria Bioscience (LEXX) Change in Acquisitions & Divestments (2014 - 2015)

Lexaria Bioscience's (LEXX) quarterly Change in Acquisitions & Divestments came in at -$678193.0 in Q1 2015, down 200.0% quarter-over-quarter from $678193.0 in Q4 2014.

Lexaria Bioscience (LEXX) Change in Acquisitions & Divestments (2014 - 2015) Analysis & Trends

Lexaria Bioscience has disclosed Change in Acquisitions & Divestments across 2 years of filings, most recently posting -$678193.0 for Q1 2015.

  • Change in Acquisitions & Divestments for Q1 2015 came in at -$678193.0, changed N/A year-over-year; the trailing twelve-month figure through Aug 2020 was -$678193.0 (changed N/A YoY), and the FY2020 annual result was $6802.0, changed N/A from the prior year.
  • Change in Acquisitions & Divestments came in at -$678193.0 for Q1 2015 at Lexaria Bioscience, down from $678193.0 in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $678193.0 in Q4 2014 to a low of -$678193.0 in Q1 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn -
7 Psyence Biomedical 238.34 Bn 238.33 Bn -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn
9 Abivax 95.45 Bn 95.45 Bn -
10 Lexaria Bioscience 7.63 Mn 2.11 Mn 20,000.00

Historic Data

Download Data
DateValue
Feb 28, 2015 -678,193.00
Feb 28, 2015 -678,193.00
Nov 30, 2014 678,193.00
Nov 30, 2014 678,193.00